Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial – The Lancet Respiratory Medicine Invited Commentary: Exploiting an early immunological window of opportunity in COVID-19 – The Lancet Respiratory Medicine
The post COLCORONA RCT: Colchicine for community-treated patients with COVID-19 – findings suggest it may lower death and hospital admission rates, but further studies are required. appeared first on Links Medicus.
Statement: The tobacco endgame—eradicating a worsening epidemic: a joint opinion from the American Heart Association, World Heart Federation, American College of Cardiology, and the European Society of Cardiology News release: Global cardiovascular organizations release joint opinion on achieving the ‘tobacco endgame’ – American College of Cardiology Commentary: The Tobacco Endgame—Eradicating a Worsening Epidemic – American […]
The post Global cardiovascular organizations release joint opinion on achieving the ‘tobacco endgame’. appeared first on Links Medicus.
Moderna says its Covid vaccine is 100% effective in teens, plans to seek FDA OK in early June – CNBC Commentary on Twitter BREAKING: Moderna study of more than 3,700 12- to 17-year olds found 100% effficacy in those who received 2-dose #covid19 #vaccine, no significant safety problems. Will apply for FDA authorization.https://t.co/l0MHiLjCcA — […]
The post Moderna says its Covid vaccine is 100% effective in teens, plans to seek FDA OK in early June. appeared first on Links Medicus.
Can people vaccinated against COVID-19 still spread the coronavirus? – The Conversation Related: Indirect Protection by Reducing Transmission: Ending the Pandemic with SARS-CoV-2 Vaccination – “Tell the hesitant: the vaccines protect both you and protect others — a lot!”
The post Can people vaccinated against COVID-19 still spread the coronavirus? – “Preliminary evidence seems to suggest the COVID-19 vaccines make it less likely someone who’s vaccinated will transmit the coronavirus”. appeared first on Links Medicus.
Single-dose SARS-CoV-2 vaccine in a prospective cohort of COVID-19 patients – medRxiv See also: SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors – EClinicalMedicine Related: Another study shows a single dose of mRNA vaccine may be enough for patients with previous Covid-19 Commentaries on Twitter If you had prior covid and […]
The post [Preprint] More data showing a single-dose SARS-CoV-2 mRNA vaccine may be enough in individuals with previous COVID-19. appeared first on Links Medicus.
COVID Morbidity – Science-Based Medicine
The post COVID Morbidity – The emerging burden of long COVID is significant, and needs to be considered when evaluating the risk vs. benefit of pandemic measures. appeared first on Links Medicus.
Count the cost of disability caused by COVID-19 – Nature
The post Count the cost of disability caused by COVID-19 – “Focusing only on cases and deaths hides the pandemic’s lasting health burden on people, societies and economies”. appeared first on Links Medicus.
Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review – JAMA Network Open Commentary: Seven out of ten hospitalized COVID-19 patients will have long-haul symptoms – MedicalXpress
The post Systematic review of 45 studies including 9751 participants, most of which were hospitalized, found 73% had at least 1 persistent symptom for weeks after Covid-19. appeared first on Links Medicus.
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial – JAMA Commentary: China’s Sinopharm Publishes Awaited Covid Vaccine Study Details – Bloomberg Commentary on Twitter (thread – click for more) The #4Humanity phase 3 trial of Sinopharm's Beijing & Wuhan vaccines published in JAMA by @NawalAlKaabi &co […]
The post RCT: 2 inactivated SARS-CoV-2 vaccines show efficacy of 72.8% and 78.1% on symptomatic COVID-19 infection in adults. appeared first on Links Medicus.
Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials – medRxiv Commentary on Twitter ???PreprintIvermectin for the treatment of #COVID19 : A systematic review & meta-analysis of RCTs10 RCTs1173 patients 8 RCTs➡️ Mild1 RCT ➡️ Moderate1 RCT➡️ Mild& modIvermectin did not reduce all-cause mortality,length of stay or viral […]
The post [Preprint] Meta-analysis of RCT: Ivermectin for the treatment of COVID-19 – no effect on all-cause mortality, length of stay, or viral clearance appeared first on Links Medicus.